{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:23:48Z","timestamp":1751466228222},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:00:00Z","timestamp":1661644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T00:00:00Z","timestamp":1661644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mid-Regional pro-Adrenomedullin (MR-proADM) is an inflammatory biomarker that improves the prognostic assessment of patients with sepsis, septic shock and organ failure. Previous studies of MR-proADM have primarily focussed on bacterial infections. A limited number of small and monocentric studies have examined MR-proADM as a prognostic factor in patients infected with SARS-CoV-2, however there is need for multicenter validation. An evaluation of its utility in predicting need for hospitalisation in viral infections was also performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An observational retrospective analysis of 1861 patients, with SARS-CoV-2 confirmed by RT-qPCR, from 10 hospitals across Europe was performed. Biomarkers, taken upon presentation to Emergency Departments (ED), clinical scores, patient demographics and outcomes were collected. Multiclass random forest classifier models were generated as well as calculation of area under the curve analysis. The primary endpoint was hospital admission with and without death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients suitable for safe discharge from Emergency Departments could be identified through an MR-proADM value of\u2009\u2264\u20091.02\u00a0nmol\/L in combination with a CRP (C-Reactive Protein) of\u2009\u2264\u200920.2\u00a0mg\/L and age\u2009\u2264\u200964, or in combination with a SOFA (Sequential Organ Failure Assessment) score\u2009&lt;\u20092 if MR-proADM was\u2009\u2264\u20090.83\u00a0nmol\/L regardless of age. Those at an increased risk of mortality could be identified upon presentation to secondary care with an MR-proADM value of\u2009&gt;\u20090.85\u00a0nmol\/L, in combination with a SOFA score\u2009\u2265\u20092 and LDH\u2009&gt;\u2009720 U\/L, or in combination with a CRP\u2009&gt;\u200929.26\u00a0mg\/L and age\u2009\u2264\u200964, when MR-proADM was\u2009&gt;\u20091.02\u00a0nmol\/L.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This international study suggests that for patients presenting to the ED with confirmed SARS-CoV-2 infection, MR-proADM in combination with age and CRP or with the patient\u2019s SOFA score could identify patients at low risk where outpatient treatment may be safe.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02151-1","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T08:02:43Z","timestamp":1661673763000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin"],"prefix":"10.1186","volume":"23","author":[{"given":"Emanuela","family":"Sozio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ripoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Rumbolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Minieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Boverio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Rodr\u00edguez Mulero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lainez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Gregoriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Brazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Terrinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Callegari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Hern\u00e1ndez Olivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Esteban-Torrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael","family":"Calcerrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sbrana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iria","family":"Miguens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo M.","family":"Legramante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Montrucchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito N.","family":"Di Lecce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto C.","family":"Lauritano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Garc\u00eda de Guadiana-Romualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gonz\u00e1lez del Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Bernal-Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Andaluz-Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kordo","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,28]]},"reference":[{"issue":"13","key":"2151_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA"},{"issue":"16","key":"2151_CR2","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/cid\/ciaa576","volume":"71","author":"JJY Zhang","year":"2020","unstructured":"Zhang JJY, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe disease and efficacy of treatment in patients infected with covid-19: a systematic review, meta-analysis, and meta-regression analysis. Clin Infect Dis. 2020;71(16):2199\u2013206.","journal-title":"Clin Infect Dis"},{"issue":"10234","key":"2151_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417\u20138.","journal-title":"Lancet"},{"issue":"5","key":"2151_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/BCR.0000000000000508","volume":"38","author":"J Gille","year":"2017","unstructured":"Gille J, Ostermann H, Dragu A, Sablotzki A. MR-proADM: a new biomarker for early diagnosis of sepsis in burned patients. J Burn Care Res. 2017;38(5):290\u20138.","journal-title":"J Burn Care Res"},{"issue":"1","key":"2151_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13054-018-2084-z","volume":"22","author":"G Elke","year":"2018","unstructured":"Elke G, Bloos F, Wilson DC, Meybohm P, Group SCCT. Identification of developing multiple organ failure in sepsis patients with low or moderate SOFA scores. Crit Care. 2018;22(1):147.","journal-title":"Crit Care"},{"issue":"1","key":"2151_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13054-018-2001-5","volume":"22","author":"G Elke","year":"2018","unstructured":"Elke G, Bloos F, Wilson DC, et al. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial. Crit Care. 2018;22(1):79.","journal-title":"Crit Care"},{"issue":"1","key":"2151_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-019-2329-5","volume":"23","author":"K Saeed","year":"2019","unstructured":"Saeed K, Wilson DC, Bloos F, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Crit Care. 2019;23(1):40.","journal-title":"Crit Care"},{"issue":"4","key":"2151_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14737159.2021.1902312","volume":"21","author":"K Saeed","year":"2021","unstructured":"Saeed K, Legramante JM, Angeletti S, et al. Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department. Expert Rev Mol Diagn. 2021;21(4):397\u2013404.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"2151_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13054-019-2613-4","volume":"23","author":"J Gonzalez Del Castillo","year":"2019","unstructured":"Gonzalez Del Castillo J, Wilson DC, Clemente-Callejo C, et al. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission. Crit Care. 2019;23(1):335.","journal-title":"Crit Care"},{"key":"2151_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2021.03.041","volume":"88","author":"J Gonzalez Del Castillo","year":"2021","unstructured":"Gonzalez Del Castillo J, Clemente-Callejo C, Llopis F, et al. Midregional proadrenomedullin safely reduces hospitalization in a low severity cohort with infections in the ED: a randomized controlled multi-centre interventional pilot study. Eur J Intern Med. 2021;88:104\u201313.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2151_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s13054-020-03151-7","volume":"24","author":"DC Wilson","year":"2020","unstructured":"Wilson DC, Schefold JC, Baldir\u00e0 J, Spinetti T, Saeed K, Elke G. Adrenomedullin in COVID-19 induced endotheliitis. Crit Care. 2020;24(1):411.","journal-title":"Crit Care"},{"issue":"5","key":"2151_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1515\/cclm-2020-1295","volume":"59","author":"C Gregoriano","year":"2021","unstructured":"Gregoriano C, Koch D, Kutz A, et al. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study. Clin Chem Lab Med. 2021;59(5):995\u20131004.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2151_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246771","volume":"16","author":"G Montrucchio","year":"2021","unstructured":"Montrucchio G, Sales G, Rumbolo F, et al. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS ONE. 2021;16(2): e0246771.","journal-title":"PLoS ONE"},{"issue":"1","key":"2151_CR14","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/s41598-021-84478-1","volume":"11","author":"E Sozio","year":"2021","unstructured":"Sozio E, Tascini C, Fabris M, et al. MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep. 2021;11(1):5121.","journal-title":"Sci Rep"},{"issue":"6","key":"2151_CR15","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s11739-021-02756-2","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Henry BM. Pooled analysis of mid-regional pro-adrenomedullin values in COVID-19 patients with critical illness. Intern Emerg Med. 2021;16(6):1723\u20135.","journal-title":"Intern Emerg Med"},{"key":"2151_CR16","doi-asserted-by":"crossref","unstructured":"Garc\u00eda de Guadiana-Romualdo L, Calvo Nieves MD, Rodr\u00edguez Mulero MD, et al. MR-proADM as marker of endotheliitis predicts COVID-19 severity. Eur J Clin Invest. 2021;51(5):e13511.","DOI":"10.1111\/eci.13511"},{"key":"2151_CR17","doi-asserted-by":"publisher","unstructured":"MooreN, Williams R, Mori M, et al. Mid-Regional pro-Adrenomedullin (MR-proADM), C-Reactive Protein (CRP) and other biomarkers in the early identification of disease progression in covid-19 patients in the acute NHS Setting. 2021. https:\/\/doi.org\/10.1101\/2021.04.19.21252978v2","DOI":"10.1101\/2021.04.19.21252978v2"},{"key":"2151_CR18","doi-asserted-by":"crossref","unstructured":"Garc\u00eda de Guadiana-Romualdo L, Mart\u00ednez Mart\u00ednez M, Rodr\u00edguez Mulero MD, et al. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients. Int J Infect Dis. 2021;111:211\u20138.","DOI":"10.1016\/j.ijid.2021.08.058"},{"key":"2151_CR19","unstructured":"Leonardis F, Minieri M, Lia MS, et al. Early predictive value of MR-proADM in critically ill patients with covid-19: an observational study in the emergency department. 2021. http:\/\/www.annexpublishers.com\/articles\/JEMC\/4103-Early-Predictive-Value-of-MR-proADM.pdf. Accessed 10 Oct 2021."},{"issue":"12","key":"2151_CR20","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","volume":"61","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61(12):1446\u201352.","journal-title":"Clin Chem"},{"key":"2151_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"M Kursa","year":"2010","unstructured":"Kursa M, Rudnicki W. Feature selection with the boruta package. J Stat Softw. 2010;36:1\u201313.","journal-title":"J Stat Softw"},{"issue":"1","key":"2151_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"issue":"3","key":"2151_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1198\/106186006X133933","volume":"15","author":"T Hothorn","year":"2006","unstructured":"Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651\u201374.","journal-title":"J Comput Graph Stat"},{"key":"2151_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing."},{"issue":"6","key":"2151_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710\u20138.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2151_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J, et al. Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes. Stat Med. 2019;38(7):1276\u201396.","journal-title":"Stat Med"},{"key":"2151_CR27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01104-2020","author":"G Wu","year":"2020","unstructured":"Wu G, Yang P, Xie Y, et al. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.01104-2020.","journal-title":"Eur Respir J"},{"key":"2151_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.699880","volume":"8","author":"K Zhang","year":"2021","unstructured":"Zhang K, Zhang X, Ding W, et al. The prognostic accuracy of national early warning score 2 on predicting clinical deterioration for patients with COVID-19: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8: 699880.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2151_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-021-02720-w","volume":"19","author":"V Sch\u00f6ning","year":"2021","unstructured":"Sch\u00f6ning V, Liakoni E, Baumgartner C, et al. Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital. J Transl Med. 2021;19(1):56.","journal-title":"J Transl Med"},{"key":"2151_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000729","author":"P Bradley","year":"2020","unstructured":"Bradley P, Frost F, Tharmaratnam K, Wootton DG. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res. 2020. https:\/\/doi.org\/10.1136\/bmjresp-2020-000729.","journal-title":"BMJ Open Respir Res"},{"key":"2151_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2334-11-112","volume":"11","author":"WC Albrich","year":"2011","unstructured":"Albrich WC, Dusemund F, R\u00fcegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011;11:112.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2151_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jinf.2018.05.007","volume":"77","author":"JE Stalenhoef","year":"2018","unstructured":"Stalenhoef JE, van Nieuwkoop C, Wilson DC, et al. Biomarker guided triage can reduce hospitalization rate in community acquired febrile urinary tract infection. J Infect. 2018;77(1):18\u201324.","journal-title":"J Infect"},{"key":"2151_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fphys.2020.00747","volume":"11","author":"A Colantuoni","year":"2020","unstructured":"Colantuoni A, Martini R, Caprari P, et al. COVID-19 sepsis and microcirculation dysfunction. Front Physiol. 2020;11:747.","journal-title":"Front Physiol"},{"issue":"10235","key":"2151_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet. 2020;395(10235):1517\u201320.","journal-title":"The Lancet"},{"key":"2151_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100057","volume":"8","author":"D Liu","year":"2020","unstructured":"Liu D, Wang Q, Zhang H, et al. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19). Med Drug Discov. 2020;8: 100057.","journal-title":"Med Drug Discov"},{"issue":"8","key":"2151_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"3","key":"2151_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00134-007-0955-x","volume":"34","author":"MD de Kruif","year":"2008","unstructured":"de Kruif MD, Lemaire LC, Giebelen IA, et al. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med. 2008;34(3):518\u201322.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2151_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","volume":"45","author":"C Ince","year":"2016","unstructured":"Ince C, Mayeux PR, Nguyen T, et al. The endothelium in sepsis. Shock. 2016;45(3):259\u201370.","journal-title":"Shock"},{"issue":"4","key":"2151_CR39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/JLB.5A0817-324R","volume":"103","author":"Z Xie","year":"2018","unstructured":"Xie Z, Chen WS, Yin Y, et al. Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease). J Leukoc Biol. 2018;103(4):749\u201359.","journal-title":"J Leukoc Biol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T08:09:58Z","timestamp":1661674198000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2151"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02151-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,28]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was sought from the relevant boards or governance bodies of each participating hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Thermofisher provided reagents for measurement of MR-proADM free of charge to some sites involved. KS has received research grants from Pfizer and Thermofisher. CT has received funds for speaking at symposia organized on behalf of Novartis, Merck, Thermofisher, Angelini, Biomerieux, Basilea, Correvio, Zambon, Hikma and Astellas. LB has received founds for speaking at symposia organized with the non-conditioning contribution of MSD, BD, Gilead, Ambu, Biotest, Medtronic and to take part to advisory boards organized by Ambu, Janssen, Gilead. FR has received funds for speaking at symposia organized on behalf of Thermofisher. GM has received funds for speaking at symposia organized on behalf of Thermofisher, Gilead, Pfizer, Ambu.\u00a0The institution of PS has received research support from Thermofisher, bioMerieux, Nestle and Abbott.\u00a0 However, these had no role in study conception or design, the collection, management, analysis, or interpretation of the data, in the preparation, review, or approval of the manuscript, or in the decision to submit the manuscript for publication. There are no non-financial interests. Other authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}